SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial

BACKGROUND: Additional outpatient therapies which are readily accessible will be essential to reduce COVID-19 illness progression in high risk individuals. Especially as the virus continues to mutate with greater transmissibility despite increased global vaccination. METHODS: A randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, Monika, Wu, Wen, Moore, Keith, Winchester, Stephen, Tu, Yuan-Po, Miller, Christopher, Kodgule, Rahul, Pendse, Amol, Rangwala, Shabbir, Joshi, Shashank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239922/
https://www.ncbi.nlm.nih.gov/pubmed/35784831
http://dx.doi.org/10.1016/j.lansea.2022.100036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239922/
https://www.ncbi.nlm.nih.gov/pubmed/35784831
http://dx.doi.org/10.1016/j.lansea.2022.100036

Ejemplares similares